The number of people diagnosed with melanoma skin cancer each year in the UK is increasing at an alarming rate. Professor Mark Middleton's research could lead to new tests to help doctors predict whether a drug called Avastin can help prevent an individual's melanoma from returning after surgery. Rich Guerin shares his experience with melanoma, and why it's so important to support this research.
